We evaluated serum soluble lipoprotein receptor 11 of #KawasakiDisease patients. Using a cutoff value of >17.6 ng/mL, we identified the non-responders (to a second dose of #IVIG) with a sensitivity of 73.3% and a specificity of 79.1%. #小児循環研究室
https://t.co/6qgPbH4iW3 https://t.co/XIlahKlyyW
In all #KawasakiDisease patients, serum soluble lipoprotein receptor 11 (#sLR11) levels were elevated after intravenous immunoglobulin therapy. There was a decreased but sustained high level in the convalescent stage. #Pediatrics #小児循環研究室
https://t.co/6qgPbH4iW3 https://t.co/OQMKbdPqV7
Serum soluble lipoprotein receptor 11 levels before intravenous immunoglobulin therapy were higher in all #KawasakiDisease patients. Serum #sLR11 levels before #IVIG therapy were higher in non-responders than in controls or responders. #小児循環研究室
https://t.co/6qgPbHllY3 https://t.co/gyEdHRO5UP
We revealed that the hyponatremia development age is earlier (within 7days) than the previously described time-point in babies with salt-wasting-type-21-hydroxylase deficiency. #CongenitalAdrenalHyperplasia #NewbornScreening #NBS #21OHD #小児内分泌研究室
https://t.co/Nh8BMg4JeC
We evaluated soluble lipoprotein receptor 11 of #KawasakiDisease patients. Serum #sLR11 levels before intravenous immunoglobulin were higher in #IVIG non-responders than in responders or afebrile controls. #Pediatrics #PediatricCardiology #小児循環研究室
https://t.co/6qgPbHllY3
When cardiac fibroblasts from restrictive cardiomyopathy patients were co-cultured with healthy cardiomyocytes, the relaxation velocity was impaired. Fibroblasts might affect pathological behavior of cardiomyocytes. #TNNI3 #RCM #小児循環研究室 @JCIRC_IPR
https://t.co/zrcYDkQ9cA